Inno Supps Night Shred GLP-1 Review (2026): Does the 'GLP-1' Fat Burner Work?
You saw the ad — a testimonial claiming someone dropped nearly 30 pounds after adding Inno Supps Night Shred GLP-1. Before you subscribe, here's the honest, sourced breakdown: this is an over-the-counter herbal-and-melatonin capsule that borrows the 'GLP-1' name from prescription drugs like Ozempic and Wegovy — but it contains none of those medicines, and experts say this category is most likely ineffective for real weight loss.
What's actually in the bottle
Despite the 'GLP-1' branding, Night Shred GLP-1 is a nighttime supplement. Reporting on the formula describes a blend built around Akkermansia muciniphila and Sukré aimed at 'naturally' elevating GLP-1, plus grains of paradise (Paradoxine), GreenSelect green tea, saffron, Sensoril ashwagandha, GABA and melatonin. Inno Supps' own product page says the formula uses Berberine and Sukré to stimulate the body to increase production of GLP-1.
None of those are GLP-1 receptor agonist drugs. The prescription medicines the name evokes — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are FDA-approved drugs; this is a supplement carrying the standard 'these statements have not been evaluated by the Food and Drug Administration' disclaimer.
Why 'boost your natural GLP-1' probably doesn't do what the ad implies
Experts who spoke to NBC News were blunt: supplements claiming to boost the body's natural GLP-1 are most likely ineffective for weight loss. The reason is pharmacological — natural GLP-1's release into the bloodstream is fleeting, while GLP-1 drugs work by mimicking the hormone and keeping it around far longer. That NBC piece specifically noted Inno Supps' related Trim Biome GLP-1 markets 'clinically studied ingredients' but not the hormone in the product's name.
The berberine angle doesn't rescue it either. Pharmacists note berberine has been nicknamed 'nature's Ozempic' online, but that assertion is misleading and not supported by scientific evidence, and a systematic review found robust clinical data for meaningful weight loss lacking.
The legal warning shot for this exact marketing angle
A near-identical pitch — a capsule that 'boosts your natural GLP-1' — has already triggered litigation against another brand, Lemme. Class-action complaints allege that Lemme had no clinical evidence that increasing naturally occurring GLP-1 has any effect on calories consumed, with one plaintiff saying she gained five pounds while taking it. Court filings further allege the cited studies showed only a roughly 17% GLP-1 increase and failed to show any decrease in body weight, BMI or waist/hip ratio. These are allegations that remain to be tested in court, but they map directly onto the mechanism Inno Supps invokes.
What regulators are watching in the GLP-1 space
The FDA has warned that unapproved versions of GLP-1 drugs don't undergo FDA review for safety, effectiveness and quality, and has issued warning letters to online sellers whose marketing implied their products were the same as an FDA-approved product when they are not. Separately, the FTC alleged in a 2025 action against telehealth firm NextMed that the company made unsubstantiated weight-loss claims, used fake testimonials and distorted reviews. The dramatic testimonial in this ad is the kind of claim that draws that scrutiny.
Cost, subscriptions and complaints
Pricing runs about $69.99 per bottle, dropping toward $44.99 with bulk or subscription. Purchases enroll you in AutoRefill unless you cancel. Inno Supps holds a mid-tier rating on Trustpilot and is BBB-accredited, though the BBB profile shows complaints including billing and subscription-cancellation disputes. As always, read the return and auto-refill terms before you buy.
Red flags we found
- Uses the 'GLP-1' drug name for a product that contains no GLP-1 medication — FDA has warned sellers whose marketing implies equivalence to approved GLP-1 drugs (FDA warning letter).
- Dramatic before/after testimonial ('192 to 164 lbs') — exactly the unsubstantiated claim style the FTC has targeted in enforcement (FTC v. NextMed).
- The 'boost natural GLP-1' mechanism has drawn class-action lawsuits alleging no clinical basis for hunger/weight benefits (Robins v. Lemme allegations).
- Auto-refill subscription enrollment plus BBB complaints about billing and cancellation.
What to do instead — the legitimate paths
This is the part the ads skip: the real, verified ways to make an actual GLP-1 affordable.
💸 The real cheapest paths
Every legitimate way to lower the price of an actual, prescribed GLP-1 right now.
💊 The $149 GLP-1 pill — Foundayo
The first oral GLP-1, a real medication, self-pay from $149/mo.
🌉 Medicare GLP-1 Bridge
Part D members may reach ~$50/mo for a real GLP-1 through the new Bridge.
📝 Appeal a denial
Denied a real GLP-1? Most denials are beatable — steps plus a letter template.
Frequently asked questions
No. It's an over-the-counter dietary supplement, not a prescription drug. The prescription GLP-1 medicines are semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound); this product contains herbal and sleep ingredients instead. The FDA has warned sellers whose marketing implies a product is the same as an FDA-approved drug when it is not.
There's no good evidence it produces the dramatic results advertised. Experts told NBC News that supplements claiming to boost natural GLP-1 are most likely ineffective for weight loss because natural GLP-1's effect is short-lived. The melatonin and GABA may help some people sleep, but that's different from the fat-loss claim in the ad.
Not according to pharmacists. Berberine's nickname 'nature's Ozempic' is misleading and not supported by scientific evidence, with robust clinical weight-loss data lacking.
Purchases can enroll you in AutoRefill unless you cancel, and the company's BBB profile shows complaints involving billing and subscription cancellation. Review the terms carefully before ordering.
Sources
- Inno Supps official Night Shred GLP-1 product page (ingredients, GLP-1 claims, auto-refill terms) — https://www.innosupps.com/products/night-shred-glp1 · accessed July 13, 2026
- Stack3d — formula breakdown and pricing for Night Shred GLP-1 — https://www.stack3d.com/2024/11/inno-supps-night-shred-glp-1.html · accessed July 13, 2026
- NBC News — experts say GLP-1-boosting supplements are most likely ineffective; names Inno Supps' Trim Biome GLP-1 — https://www.nbcnews.com/health/health-news/glp-1-supplements-weight-loss-science-what-know-rcna201921 · accessed July 13, 2026
- Pharmacy Times — 'Is Berberine Nature's GLP-1?' (berberine claim not supported by evidence) — https://www.pharmacytimes.com/view/is-berberine-nature-s-glp-1- · accessed July 13, 2026
- ClassAction.org — Lemme lawsuit alleging no clinical basis for natural-GLP-1 weight-loss claims — https://www.classaction.org/news/lemme-lawsuit-claims-glp-1-weight-loss-capsules-not-as-effective-as-advertised · accessed July 13, 2026
- National Law Review — details of the two Lemme GLP-1 class actions (17% GLP-1, no weight/BMI change) — https://natlawreview.com/article/two-class-actions-target-supplement-promoted-increasing-glp-1 · accessed July 13, 2026
- FDA — Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss · accessed July 13, 2026
- FDA warning letter (GLP-1 Solution) — marketing implying products are same as FDA-approved drug is misleading — https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glp-1-solution-715883-09092025 · accessed July 13, 2026
- FTC — final order against NextMed over deceptive GLP-1 weight-loss advertising and fake testimonials — https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-approves-final-order-against-telehealth-provider-nextmed-over-charges-it-used-deceptive · accessed July 13, 2026
- BBB — Inno Supps complaints (billing and subscription-cancellation disputes) — https://www.bbb.org/us/nv/henderson/profile/vitamins-and-supplements/inno-supps-1086-90076072/complaints · accessed July 13, 2026
Independence: we have no affiliate or business relationship with any product reviewed on this page and accept nothing from the brands. If a clearly-labeled partner option ever appears in the "legitimate paths" section, it never changes the verdict or which lowest-cost path we show first.